Every Form 4 that ELITE HEALTH SYSTEMS (EHSI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow EHSI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EHSI filings page.
Elite Health Systems Inc. (EHSI) reported that CEO, director, and greater-than-10% owner jeereddi Prasad Anjaneya received a grant of 68,421 common stock warrants on August 31, 2026, with an exercise price of $0.95 per share and expiration on August 31, 2031. Following this grant, he holds 178,947 warrants in total. His reported common stock holdings are 3,624,484 shares directly and 225,716 shares indirectly through an entity where he is a managing member and major equity owner. No Rule 10b5-1 trading plan is reported.
Elite Health Systems Inc. reported that CEO and 10% owner Jeereddi Prasad Anjaneya received a grant of 110,526 common stock warrants on July 31, 2026, with a $0.95 per-share exercise price and a July 31, 2031 expiration. Following this grant, he holds 3,624,484 common shares directly, 225,716 common shares indirectly through an entity, and the granted warrants.
Elite Health Systems Inc. CEO and director Jeereddi Prasad Anjaneya reported an open-market purchase of common stock. On this Form 4, he bought 42,105 shares of Elite Health Systems common stock at $0.95 per share, classified as a direct holding. After this transaction, he directly owns 3,624,484 common shares. A separate entry reports 225,716 common shares held indirectly through an entity for which he is a managing member and major equity owner, giving investors a view of both his direct and indirect equity exposure.
Elite Health Systems Inc. CEO Jeereddi Prasad Anjaneya reported two open-market purchases of the company’s Common Stock through an affiliated entity, Haven Hospital LLC. The transactions totaled 12,000 shares at a price of $1.05 per share.
Each purchase involved 6,000 shares, executed on May 15 and June 1, 2026. Following these indirect acquisitions by Haven Hospital LLC, the reporting person’s indirect holdings increased to 239,423 shares of Common Stock.
Elite Health Systems Inc. director and CEO Jeereddi Prasad Anjaneya reported an indirect open-market purchase of 1,707 shares of Common Stock at $1.08 per share on April 29, 2026. After this transaction, the indirectly held position through Haven Hospital LLC totaled 227,423 shares.
Elite Health Systems Inc. insider report: CEO, director and 10% owner Prasad A. Jeereddi reported indirect purchases of Elite Health Systems Inc. common stock. On January 6, 2026, an entity of which he is a managing member and major equity owner acquired 400 shares of common stock at $1.33 per share. On January 8, 2026, the same entity acquired an additional 3,202 shares at $1.43 per share. Following these transactions, this entity held 225,716 indirectly owned shares, while Jeereddi also reported a separate directly held position of 3,356,663 shares of common stock.